Adiponectin multimers in maternal plasma

References

• Buchanan T A, Metzger B E, Freinkel N, Bergman R N. Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol 1990; 162: 1008–1014
   PubMed Web of Science ®Google Scholar
• Burt R L. Peripheral utilization of glucose in pregnancy. III. Insulin tolerance. Obstet Gynecol 1956; 7: 658–664
   Google Scholar
• Butte N F. Carbohydrate and lipid metabolism in pregnancy: Normal compared with gestational diabetes mellitus. Am J Clin Nutr 2000; 71: 1256S–1261S
   PubMed Web of Science ®Google Scholar
• Catalano P M, Tyzbir E D, Roman N M, Amini S B, Sims E A. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol 1991; 165: 1667–1672
   PubMed Web of Science ®Google Scholar
• Catalano P M, Roman-Drago N M, Amini S B, Sims E A. Longitudinal changes in body composition and energy balance in lean women with normal and abnormal glucose tolerance during pregnancy. Am J Obstet Gynecol 1998; 179: 156–165
   PubMed Web of Science ®Google Scholar
• Fisher P M, Sutherland H W, Bewsher P D. The insulin response to glucose infusion in normal human pregnancy. Diabetologia 1980; 19: 15–20
   PubMedGoogle Scholar
• Kuhl C. Glucose metabolism during and after pregnancy in normal and gestational diabetic women. 1. Influence of normal pregnancy on serum glucose and insulin concentration during basal fasting conditions and after a challenge with glucose. Acta Endocrinol (Copenh) 1975; 79: 709–719
   PubMedGoogle Scholar
• Langer O, Anyaegbunam A, Brustman L, Guidetti D, Mazze R. Gestational diabetes: Insulin requirements in pregnancy. Am J Obstet Gynecol 1987; 157: 669–675
   PubMed Web of Science ®Google Scholar
• Lind T, Bell S, Gilmore E, Huisjes H J, Schally A V. Insulin disappearance rate in pregnant and non-pregnant women, and in non-pregnant women given GHRIH. Eur J Clin Invest 1977; 7: 47–52
   PubMedGoogle Scholar
• Phelps R L, Metzger B E, Freinkel N. Carbohydrate metabolism in pregnancy. XVII. Diurnal profiles of plasma glucose, insulin, free fatty acids, triglycerides, cholesterol, and individual amino acids in late normal pregnancy. Am J Obstet Gynecol 1981; 140: 730–736
   PubMed Web of Science ®Google Scholar
• Reece E A, Homko C, Wiznitzer A. Metabolic changes in diabetic and nondiabetic subjects during pregnancy. Obstet Gynecol Surv 1994; 49: 64–71
   PubMedGoogle Scholar
• Ryan E A, O'Sullivan M J, Skyler J S. Insulin action during pregnancy. Studies with the euglycemic clamp technique. Diabetes 1985; 34: 380–389
   PubMed Web of Science ®Google Scholar
• Spellacy W N, Goetz F C, Greenberg B Z, Ells J. Plasma insulin in normal ‘early’ pregnancy. Obstet Gynecol 1965; 25: 862–865
   Google Scholar
• Coustan D R, Carpenter M W. The diagnosis of gestational diabetes. Diabetes Care 1998; 21(Suppl 2)B5–8
   PubMedGoogle Scholar
• Buchanan T A, Xiang A H. Gestational diabetes mellitus. J Clin Invest 2005; 115: 485–491
   PubMed Web of Science ®Google Scholar
• Kuhl C. Aetiology of gestational diabetes. Baillieres Clin Obstet Gynaecol 1991; 5: 279–292
   PubMed Web of Science ®Google Scholar
• Ryan E A. Hormones and insulin resistance during pregnancy. Lancet 2003; 362: 1777–1778
   PubMed Web of Science ®Google Scholar
• Barbour L A, Shao J, Qiao L, Pulawa L K, Jensen D R, Bartke A, Garrity M, Draznin B, Friedman J E. Human placental growth hormone causes severe insulin resistance in transgenic mice. Am J Obstet Gynecol 2002; 186: 512–517
   PubMed Web of Science ®Google Scholar
• Beck P. Progestin enhancement of the plasma insulin response to glucose in Rhesus monkeys. Diabetes 1969; 18: 146–152
   Google Scholar
• Kalkhoff R K, Richardson B L, Beck P. Relative effects of pregnancy, human placental lactogen and prednisolone on carbohydrate tolerance in normal and subclinical diabetic subjects. Diabetes 1969; 18: 153–163
   PubMed Web of Science ®Google Scholar
• Kalkhoff R K, Jacobson M, Lemper D. Progesterone, pregnancy and the augmented plasma insulin response. J Clin Endocrinol Metab 1970; 31: 24–28
   Google Scholar
• Polderman K H, Gooren L J, Asscheman H, Bakker A, Heine R J. Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab 1994; 79: 265–271
   PubMed Web of Science ®Google Scholar
• Ryan E A, Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab 1988; 67: 341–347
   PubMed Web of Science ®Google Scholar
• Samaan N, Yen S C, Gonzalez D, Pearson O H. Metabolic effects of placental lactogen (HPL) in man. J Clin Endocrinol Metab 1968; 28: 485–491
   PubMedGoogle Scholar
• Catalano P M, Hoegh M, Minium J, Huston-Presley L, Bernard S, Kalhan S, Hauguel-De M S. Adiponectin in human pregnancy: Implications for regulation of glucose and lipid metabolism. Diabetologia 2006; 49: 1677–1685
   PubMed Web of Science ®Google Scholar
• Gimeno R E, Klaman L D. Adipose tissue as an active endocrine organ: Recent advances. Curr Opin Pharmacol 2005; 5: 122–128
   PubMed Web of Science ®Google Scholar
• Hotamisligil G S, Shargill N S, Spiegelman B M. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 1993; 259: 87–91
   PubMed Web of Science ®Google Scholar
• Hotamisligil G S. Inflammation and metabolic disorders. Nature 2006; 444: 860–867
   PubMed Web of Science ®Google Scholar
• Hutley L, Prins J B. Fat as an endocrine organ: Relationship to the metabolic syndrome. Am J Med Sci 2005; 330: 280–289
   PubMed Web of Science ®Google Scholar
• Kahn B B, Flier J S. Obesity and insulin resistance. J Clin Invest 2000; 106: 473–481
   PubMed Web of Science ®Google Scholar
• Kahn S E, Hull R L, Utzschneider K M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444: 840–846
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: Contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci 1999; 892: 146–154
   PubMed Web of Science ®Google Scholar
• Montague C T, O'Rahilly S. The perils of portliness: Causes and consequences of visceral adiposity. Diabetes 2000; 49: 883–888
   PubMed Web of Science ®Google Scholar
• Spiegelman B M, Flier J S. Obesity and the regulation of energy balance. Cell 2001; 104: 531–543
   PubMed Web of Science ®Google Scholar
• Tilg H, Moschen A R. Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6: 772–783
   PubMed Web of Science ®Google Scholar
• Trayhurn P. Endocrine and signalling role of adipose tissue: New perspectives on fat. Acta Physiol Scand 2005; 184: 285–293
   PubMedGoogle Scholar
• Wellen K E, Hotamisligil G S. Inflammation, stress, and diabetes. J Clin Invest 2005; 115: 1111–1119
   PubMed Web of Science ®Google Scholar
• Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79–83
   PubMed Web of Science ®Google Scholar
• Berg A H, Combs T P, Scherer P E. ACRP30/adiponectin: An adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002; 13: 84–89
   PubMed Web of Science ®Google Scholar
• Hu E, Liang P, Spiegelman B M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996; 271: 10 697–10 703
   Google Scholar
• Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116: 1784–1792
   PubMed Web of Science ®Google Scholar
• Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996; 221: 286–289
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004; 24: 29–33
   PubMed Web of Science ®Google Scholar
• Nakano Y, Tobe T, Choi-Miura N H, Mazda T, Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem (Tokyo) 1996; 120: 803–812
   PubMed Web of Science ®Google Scholar
• Scherer P E, Williams S, Fogliano M, Baldini G, Lodish H F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26 746–26 749
   Google Scholar
• Berg A H, Scherer P E. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96: 939–949
   PubMed Web of Science ®Google Scholar
• Campfield L A, Smith F J, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546–549
   PubMed Web of Science ®Google Scholar
• Farooqi I S, Keogh J M, Kamath S, Jones S, Gibson W T, Trussell R, Jebb S A, Lip G Y, O'Rahilly S. Partial leptin deficiency and human adiposity. Nature 2001; 414: 34–35
   PubMed Web of Science ®Google Scholar
• Friedman J M. Obesity in the new millennium. Nature 2000; 404: 632–634
   PubMed Web of Science ®Google Scholar
• Halaas J L, Gajiwala K S, Maffei M, Cohen S L, Chait B T, Rabinowitz D, Lallone R L, Burley S K, Friedman J M. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543–546
   PubMed Web of Science ®Google Scholar
• Pelleymounter M A, Cullen M J, Baker M B, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540–543
   PubMed Web of Science ®Google Scholar
• Argiles J M, Lopez-Soriano J, Busquets S, Lopez-Soriano F J. Journey from cachexia to obesity by TNF. FASEB J 1997; 11: 743–751
   PubMed Web of Science ®Google Scholar
• Hotamisligil G S. The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med 1999; 245: 621–625
   PubMed Web of Science ®Google Scholar
• Uysal K T, Wiesbrock S M, Marino M W, Hotamisligil G S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997; 389: 610–614
   PubMed Web of Science ®Google Scholar
• Wang B, Jenkins J R, Trayhurn P. Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: Integrated response to TNF-alpha. Am J Physiol Endocrinol Metab 2005; 288: E731–740
   PubMed Web of Science ®Google Scholar
• Banerjee R R, Rangwala S M, Shapiro J S, Rich A S, Rhoades B, Qi Y, Wang J, Rajala M W, Pocai A, Scherer P E, et al. Regulation of fasted blood glucose by resistin. Science 2004; 303: 1195–1198
   PubMed Web of Science ®Google Scholar
• Holcomb I N, Kabakoff R C, Chan B, Baker T W, Gurney A, Henzel W, Nelson C, Lowman H B, Wright B D, Skelton N J, et al. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 2000; 19: 4046–4055
   PubMed Web of Science ®Google Scholar
• Kim K H, Lee K, Moon Y S, Sul H S. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001; 276: 11 252–11 256
   Google Scholar
• Kusminski C M, McTernan P G, Kumar S. Role of resistin in obesity, insulin resistance and type II diabetes. Clin Sci (Lond) 2005; 109: 243–256
   PubMed Web of Science ®Google Scholar
• Steppan C M, Bailey S T, Bhat S, Brown E J, Banerjee R R, Wright C M, Patel H R, Ahima R S, Lazar M A. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307–312
   PubMed Web of Science ®Google Scholar
• Despres J P, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881–887
   PubMed Web of Science ®Google Scholar
• Rosen E D, Spiegelman B M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006; 444: 847–853
   PubMed Web of Science ®Google Scholar
• Kirwan J P, Hauguel-De M S, Lepercq J, Challier J C, Huston-Presley L, Friedman J E, Kalhan S C, Catalano P M. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002; 51: 2207–2213
   PubMed Web of Science ®Google Scholar
• Lopez-Bermejo A, Fernandez-Real J M, Garrido E, Rovira R, Brichs R, Genaro P, Bach C, Cabrero D, Kihara S, Funahashi T, et al. Maternal soluble tumour necrosis factor receptor type 2 (sTNFR2) and adiponectin are both related to blood pressure during gestation and infant's birth weight. Clin Endocrinol (Oxf) 2004; 61: 544–552
   PubMed Web of Science ®Google Scholar
• McLachlan K A, O'Neal D, Jenkins A, Alford F P. Do adiponectin, TNFalpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy. Diabetes Metab Res Rev 2006; 22: 131–138
   PubMed Web of Science ®Google Scholar
• Retnakaran R, Hanley A J, Raif N, Connelly P W, Sermer M, Zinman B. Reduced adiponectin concentration in women with gestational diabetes: A potential factor in progression to type 2 diabetes. Diabetes Care 2004; 27: 799–800
   PubMed Web of Science ®Google Scholar
• Silha J V, Krsek M, Skrha J V, Sucharda P, Nyomba B L, Murphy L J. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: Correlations with insulin resistance. Eur J Endocrinol 2003; 149: 331–335
   PubMed Web of Science ®Google Scholar
• Steppan C M, Lazar M A. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 2002; 13: 18–23
   PubMed Web of Science ®Google Scholar
• Stumvoll M, Goldstein B J, van Haeften T W. Type 2 diabetes: Principles of pathogenesis and therapy. Lancet 2005; 365: 1333–1346
   PubMed Web of Science ®Google Scholar
• Farvid M S, Ng T W, Chan D C, Barrett P H, Watts G F. Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia. Diabetes Obes Metab 2005; 7: 406–413
   PubMed Web of Science ®Google Scholar
• Ahima R S, Flier J S. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000; 11: 327–332
   PubMed Web of Science ®Google Scholar
• Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: A randomized trial. JAMA 2003; 289: 1799–1804
   PubMed Web of Science ®Google Scholar
• Klok M D, Jakobsdottir S, Drent M L. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: A review. Obes Rev 2007; 8: 21–34
   PubMed Web of Science ®Google Scholar
• Yang W S, Lee W J, Funahashi T, Tanaka S, Matsuzawa Y, Chao C L, Chen C L, Tai T Y, Chuang L M. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001; 86: 3815–3819
   PubMed Web of Science ®Google Scholar
• Frayn K N. Obesity and metabolic disease: Is adipose tissue the culprit. Proc Nutr Soc 2005; 64: 7–13
   PubMed Web of Science ®Google Scholar
• Gable D R, Hurel S J, Humphries S E. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis 2006; 188: 231–244
   PubMed Web of Science ®Google Scholar
• Okamoto Y, Arita Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M, Igura T, Inui Y, Kihara S, Nakamura T, et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 2000; 32: 47–50
   PubMed Web of Science ®Google Scholar
• Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, Ohashi K, Sakai N, Shimomura I, Kobayashi H, et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002; 106: 2767–2770
   PubMed Web of Science ®Google Scholar
• Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, Ishigami M, Kuriyama H, Kishida K, Nishizawa H, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001; 103: 1057–1063
   PubMed Web of Science ®Google Scholar
• Ouchi N, Ohishi M, Kihara S, Funahashi T, Nakamura T, Nagaretani H, Kumada M, Ohashi K, Okamoto Y, Nishizawa H, et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 2003; 42: 231–234
   PubMed Web of Science ®Google Scholar
• Unger R H. Hyperleptinemia: Protecting the heart from lipid overload. Hypertension 2005; 45: 1031–1034
   Google Scholar
• Mazaki-Tovi S, Kanety H, Sivan E. Adiponectin and human pregnancy. Curr Diab Rep 2005; 5: 278–281
   PubMedGoogle Scholar
• Mazaki-Tovi S, Kanety H, Pariente C, Hemi R, Wiser A, Schiff E, Sivan E. Maternal serum adiponectin levels during human pregnancy. J Perinatol 2007; 27: 77–81
   PubMed Web of Science ®Google Scholar
• Nien J K, Mazaki-Tovi S, Romero R, Erez O, Kusanovic J P, Gotsch F, Pineles B L, Gomez R, Edwin S, Mazor M, et al. Plasma adiponectin concentrations in non-pregnant, normal and overweight pregnant women. J Perinat Med 2007
   Google Scholar
• Sivan E, Mazaki-Tovi S, Pariente C, Efraty Y, Schiff E, Hemi R, Kanety H. Adiponectin in human cord blood: Relation to fetal birth weight and gender. J Clin Endocrinol Metab 2003; 88: 5656–5660
   PubMed Web of Science ®Google Scholar
• Nien J K, Mazaki-Tovi S, Romero R, Kusanovic J P, Erez O, Gotsch F, Pineles B L, Friel L A, Espinoza J, Goncalves L, et al. Resistin: A hormone which induces insulin resistance is increased in normal pregnancy. J Perinat Med 2007
   Google Scholar
• Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J, Paschke R. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2003; 301: 1045–1050
   PubMed Web of Science ®Google Scholar
• Malamitsi-Puchner A, Briana D D, Boutsikou M, Kouskouni E, Hassiakos D, Gourgiotis D. Perinatal circulating visfatin levels in intrauterine growth restriction. Pediatrics 2007; 119: e1314–1318
   PubMed Web of Science ®Google Scholar
• Sagawa N, Yura S, Itoh H, Mise H, Kakui K, Korita D, Takemura M, Nuamah M A, Ogawa Y, Masuzaki H, et al. Role of leptin in pregnancy—a review. Placenta 2002; 23(Suppl A)S80–86
   PubMed Web of Science ®Google Scholar
• Ategbo J M, Grissa O, Yessoufou A, Hichami A, Dramane K L, Moutairou K, Miled A, Grissa A, Jerbi M, Tabka Z, et al. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 2006; 91: 4137–4143
   PubMed Web of Science ®Google Scholar
• Kautzky-Willer A, Pacini G, Tura A, Bieglmayer C, Schneider B, Ludvik B, Prager R, Waldhausl W. Increased plasma leptin in gestational diabetes. Diabetologia 2001; 44: 164–172
   PubMed Web of Science ®Google Scholar
• Kinalski M, Telejko B, Kuzmicki M, Kretowski A, Kinalska I. Tumor necrosis factor alpha system and plasma adiponectin concentration in women with gestational diabetes. Horm Metab Res 2005; 37: 450–454
   PubMed Web of Science ®Google Scholar
• Ranheim T, Haugen F, Staff A C, Braekke K, Harsem N K, Drevon C A. Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta Obstet Gynecol Scand 2004; 83: 341–347
   PubMed Web of Science ®Google Scholar
• Thyfault J P, Hedberg E M, Anchan R M, Thorne O P, Isler C M, Newton E R, Dohm G L, deVente J E. Gestational diabetes is associated with depressed adiponectin levels. J Soc Gynecol Investig 2005; 12: 41–45
   PubMedGoogle Scholar
• Williams M A, Qiu C, Muy-Rivera M, Vadachkoria S, Song T, Luthy D A. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab 2004; 89: 2306–2311
   PubMed Web of Science ®Google Scholar
• Worda C, Leipold H, Gruber C, Kautzky-Willer A, Knofler M, Bancher-Todesca D. Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus. Am J Obstet Gynecol 2004; 191: 2120–2124
   PubMed Web of Science ®Google Scholar
• Lewandowski K C, Stojanovic N, Press M, Tuck S M, Szosland K, Bienkiewicz M, Vatish M, Lewinski A, Prelevic G M, Randeva H S. Elevated serum levels of visfatin in gestational diabetes: A comparative study across various degrees of glucose tolerance. Diabetologia 2007; 50: 1033–1037
   PubMed Web of Science ®Google Scholar
• Chan T F, Chen Y L, Lee C H, Chou F H, Wu L C, Jong S B, Tsai E M. Decreased plasma visfatin concentrations in women with gestational diabetes mellitus. J Soc Gynecol Investig 2006; 13: 364–367
   PubMedGoogle Scholar
• Haider D G, Handisurya A, Storka A, Vojtassakova E, Luger A, Pacini G, Tura A, Wolzt M, Kautzky-Willer A. Visfatin response to glucose is reduced in women with gestational diabetes mellitus. Diabetes Care 2007; 30: 1889–1891
   PubMed Web of Science ®Google Scholar
• Krzyzanowska K, Krugluger W, Mittermayer F, Rahman R, Haider D, Shnawa N, Schernthaner G. Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci (Lond) 2006; 110: 605–609
   PubMed Web of Science ®Google Scholar
• Nien J K, Mazaki-Tovi S, Romero R, Erez O, Kusanovic J P, Gotsch F, Pineles B L, Gomez R, Edwin S, Mazor M, et al. Adiponectin in severe preeclampsia. J Perinat Med 2007
   Google Scholar
• Cortelazzi D, Corbetta S, Ronzoni S, Pelle F, Marconi A, Cozzi V, Cetin I, Cortelazzi R, Beck-Peccoz P, Spada A. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol (Oxf) 2007; 66: 447–453
   PubMed Web of Science ®Google Scholar
• D'Anna R, Baviera G, Corrado F, Giordano D, De V A, Nicocia G, Di B A. Adiponectin and insulin resistance in early- and late-onset pre-eclampsia. BJOG 2006; 113: 1264–1269
   PubMed Web of Science ®Google Scholar
• Haugen F, Ranheim T, Harsem N K, Lips E, Staff A C, Drevon C A. Increased plasma levels of adipokines in preeclampsia: Relationship to placenta and adipose tissue gene expression. Am J Physiol Endocrinol Metab 2006; 290: E326–333
   PubMed Web of Science ®Google Scholar
• Hendler I, Blackwell S C, Mehta S H, Whitty J E, Russell E, Sorokin Y, Cotton D B. The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia. Am J Obstet Gynecol 2005; 193: 979–983
   PubMed Web of Science ®Google Scholar
• Kajantie E, Kaaja R, Ylikorkala O, Andersson S, Laivuori H. Adiponectin concentrations in maternal serum: Elevated in preeclampsia but unrelated to insulin sensitivity. J Soc Gynecol Investig 2005; 12: 433–439
   PubMedGoogle Scholar
• Lu D, Yang X, Wu Y, Wang H, Huang H, Dong M. Serum adiponectin, leptin and soluble leptin receptor in pre-eclampsia. Int J Gynaecol Obstet 2006
   Google Scholar
• Naruse K, Yamasaki M, Umekage H, Sado T, Sakamoto Y, Morikawa H. Peripheral blood concentrations of adiponectin, an adipocyte-specific plasma protein, in normal pregnancy and preeclampsia. J Reprod Immunol 2005; 65: 65–75
   PubMed Web of Science ®Google Scholar
• Ramsay J E, Jamieson N, Greer I A, Sattar N. Paradoxical elevation in adiponectin concentrations in women with preeclampsia. Hypertension 2003; 42: 891–894
   PubMed Web of Science ®Google Scholar
• Tsuchida A, Yamauchi T, Ito Y, Hada Y, Maki T, Takekawa S, Kamon J, Kobayashi M, Suzuki R, Hara K, et al. Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 2004; 279: 30 817–30 822
   Google Scholar
• McCarthy J F, Misra D N, Roberts J M. Maternal plasma leptin is increased in preeclampsia and positively correlates with fetal cord concentration. Am J Obstet Gynecol 1999; 180: 731–736
   PubMed Web of Science ®Google Scholar
• Schiff E, Friedman S A, Baumann P, Sibai B M, Romero R. Tumor necrosis factor-alpha in pregnancies associated with preeclampsia or small-for-gestational-age newborns. Am J Obstet Gynecol 1994; 170: 1224–1229
   PubMed Web of Science ®Google Scholar
• Kershaw E E, Flier J S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548–2556
   PubMed Web of Science ®Google Scholar
• Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, Kihara S, Funahashi T, Tenner A J, Tomiyama Y, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000; 96: 1723–1732
   PubMed Web of Science ®Google Scholar
• Berg A H, Combs T P, Du X, Brownlee M, Scherer P E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001; 7: 947–953
   PubMed Web of Science ®Google Scholar
• Fruebis J, Tsao T S, Javorschi S, Ebbets-Reed D, Erickson M R, Yen F T, Bihain B E, Lodish H F. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 2001; 98: 2005–2010
   PubMed Web of Science ®Google Scholar
• Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T, Otabe S, Okada T, Eto K, et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002; 51: 536–540
   PubMed Web of Science ®Google Scholar
• Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595–1599
   PubMed Web of Science ®Google Scholar
• Kissebah A H, Sonnenberg G E, Myklebust J, Goldstein M, Broman K, James R G, Marks J A, Krakower G R, Jacob H J, Weber J, et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A 2000; 97: 14 478–14 483
   Google Scholar
• Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley R E, Tataranni P A. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930–1935
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941–946
   PubMed Web of Science ®Google Scholar
• Zacharova J, Chiasson J L, Laakso M. The common polymorphisms (single nucleotide polymorphism [SNP]+45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: The STOP-NIDDM trial. Diabetes 2005; 54: 893–899
   PubMed Web of Science ®Google Scholar
• Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, et al. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473–2476
   PubMed Web of Science ®Google Scholar
• Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000; 102: 1296–1301
   PubMed Web of Science ®Google Scholar
• Kazumi T, Kawaguchi A, Sakai K, Hirano T, Yoshino G. Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 2002; 25: 971–976
   PubMed Web of Science ®Google Scholar
• Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, Fu Y, Motone M, Yamamoto K, Matsuo A, et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004; 43: 1318–1323
   PubMed Web of Science ®Google Scholar
• Matsushita K, Yatsuya H, Tamakoshi K, Wada K, Otsuka R, Takefuji S, Sugiura K, Kondo T, Murohara T, Toyoshima H. Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men. Arterioscler Thromb Vasc Biol 2006; 26: 871–876
   PubMedGoogle Scholar
• Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 2002; 87: 2764–2769
   PubMed Web of Science ®Google Scholar
• Despres J P, Golay A, Sjostrom L. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 2005; 353: 2121–2134
   PubMed Web of Science ®Google Scholar
• Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, Funahashi T, Walsh K. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 2004; 279: 1304–1309
   PubMed Web of Science ®Google Scholar
• Shibata R, Ouchi N, Kihara S, Sato K, Funahashi T, Walsh K. Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J Biol Chem 2004; 279: 28 670–28 674
   Google Scholar
• Tsao T S, Murrey H E, Hug C, Lee D H, Lodish H F. Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J Biol Chem 2002; 277: 29 359–29 362
   Google Scholar
• Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P, et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 2003; 278: 40 352–40 363
   Google Scholar
• Aso Y, Yamamoto R, Wakabayashi S, Uchida T, Takayanagi K, Takebayashi K, Okuno T, Inoue T, Node K, Tobe T, et al. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 2006; 55: 1954–1960
   PubMed Web of Science ®Google Scholar
• Bobbert T, Rochlitz H, Wegewitz U, Akpulat S, Mai K, Weickert M O, Mohlig M, Pfeiffer A F, Spranger J. Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes 2005; 54: 2712–2719
   PubMed Web of Science ®Google Scholar
• Pajvani U B, Du X, Combs T P, Berg A H, Rajala M W, Schulthess T, Engel J, Brownlee M, Scherer P E. Structure–function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem 2003; 278: 9073–9085
   PubMed Web of Science ®Google Scholar
• Pajvani U B, Hawkins M, Combs T P, Rajala M W, Doebber T, Berger J P, Wagner J A, Wu M, Knopps A, Xiang A H, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004; 279: 12 152–12 162
   Google Scholar
• Tsao T S, Tomas E, Murrey H E, Hug C, Lee D H, Ruderman N B, Heuser J E, Lodish H F. Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J Biol Chem 2003; 278: 50 810–50 817
   Google Scholar
• Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, Funahashi T, Matsuzawa Y. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 2004; 94: e27–31
   PubMed Web of Science ®Google Scholar
• Tonelli J, Li W, Kishore P, Pajvani U B, Kwon E, Weaver C, Scherer P E, Hawkins M. Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes. Diabetes 2004; 53: 1621–1629
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003; 423: 762–769
   PubMed Web of Science ®Google Scholar
• Katsuki A, Suematsu M, Gabazza E C, Murashima S, Nakatani K, Togashi K, Yano Y, Sumida Y. Decreased high-molecular weight adiponectin-to-total adiponectin ratio in sera is associated with insulin resistance in Japanese metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Care 2006; 29: 2327–2328
   Google Scholar
• Abbasi F, Chang S A, Chu J W, Ciaraldi T P, Lamendola C, McLaughlin T, Reaven G M, Reaven P D. Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes. Am J Physiol Regul Integr Comp Physiol 2006; 290: R139–144
   PubMed Web of Science ®Google Scholar
• Basu R, Pajvani U B, Rizza R A, Scherer P E. Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: Differential regulation from nondiabetic subjects. Diabetes 2007; 56: 2174–2177
   PubMed Web of Science ®Google Scholar
• Komaba H, Igaki N, Goto S, Yokota K, Doi H, Takemoto T, Kohno M, Hirosue Y, Goto T. Increased serum high-molecular-weight complex of adiponectin in type 2 diabetic patients with impaired renal function. Am J Nephrol 2006; 26: 476–482
   PubMedGoogle Scholar
• Nakashima R, Kamei N, Yamane K, Nakanishi S, Nakashima A, Kohno N. Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J Clin Endocrinol Metab 2006; 91: 3873–3877
   PubMed Web of Science ®Google Scholar
• Araki S, Dobashi K, Kubo K, Asayama K, Shirahata A. High molecular weight, rather than total, adiponectin levels better reflect metabolic abnormalities associated with childhood obesity. J Clin Endocrinol Metab 2006; 91: 5113–5116
   PubMed Web of Science ®Google Scholar
• Engl J, Bobbert T, Ciardi C, Laimer M, Tatarczyk T, Kaser S, Weiss H, Molnar C, Tilg H, Patsch J R, et al. Effects of pronounced weight loss on adiponectin oligomer composition and metabolic parameters. Obesity (Silver Spring) 2007; 15: 1172–1178
   PubMedGoogle Scholar
• Salani B, Briatore L, Andraghetti G, Adami G F, Maggi D, Cordera R. High-molecular weight adiponectin isoforms increase after biliopancreatic diversion in obese subjects. Obesity (Silver Spring) 2006; 14: 1511–1514
   Google Scholar
• Swarbrick M M, ustrheim-Smith I T, Stanhope K L, Van L, Ali M R, Wolfe B M, Havel P J. Circulating concentrations of high-molecular-weight adiponectin are increased following Roux-en-Y gastric bypass surgery. Diabetologia 2006; 49: 2552–2558
   PubMedGoogle Scholar
• Inoue T, Kotooka N, Morooka T, Komoda H, Uchida T, Aso Y, Inukai T, Okuno T, Node K. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease. Am J Cardiol 2007; 100: 569–574
   PubMed Web of Science ®Google Scholar
• Oki K, Koide J, Nakanishi S, Nakashima R, Yamane K. Fenofibrate increases high molecular weight adiponectin in subjects with hypertriglyceridemia. Endocr J 2007; 54: 431–435
   PubMedGoogle Scholar
• Aroda V, Ciaraldi T P, Chang S A, Dahan M H, Chang R J, Henry R R. Circulating and cellular adiponectin in polycystic ovary syndrome: Relationship to glucose tolerance and insulin action. Fertil Steril 2007
   Google Scholar
• Bluher M, Brennan A M, Kelesidis T, Kratzsch J, Fasshauer M, Kralisch S, Williams C J, Mantzoros C S. Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: Comparative evaluation of three assays. Diabetes Care 2007; 30: 280–285
   PubMed Web of Science ®Google Scholar
• Fisher F F, Trujillo M E, Hanif W, Barnett A H, McTernan P G, Scherer P E, Kumar S. Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males. Diabetologia 2005; 48: 1084–1087
   PubMed Web of Science ®Google Scholar
• Glintborg D, Frystyk J, Hojlund K, Andersen K K, Henriksen J E, Hermann A P, Hagen C, Flyvbjerg A, Andersen M. Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome. Clin Endocrinol (Oxf) 2007
   Google Scholar
• Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006; 29: 1357–1362
   PubMed Web of Science ®Google Scholar
• Modan-Moses D, Stein D, Pariente C, Yaroslavsky A, Ram A, Faigin M, Loewenthal R, Yissachar E, Hemi R, Kanety H. Modulation of adiponectin and leptin during refeeding of female anorexia nervosa patients. J Clin Endocrinol Metab 2007; 92: 1843–1847
   PubMed Web of Science ®Google Scholar
• O'Leary V B, Jorett A E, Marchetti C M, Gonzalez F, Phillips S A, Ciaraldi T P, Kirwan J P. Enhanced adiponectin multimer ratio and skeletal muscle adiponectin receptor expression following exercise training and diet in older insulin-resistant adults. Am J Physiol Endocrinol Metab 2007; 293: E421–427
   PubMedGoogle Scholar
• Schober F, Neumeier M, Weigert J, Wurm S, Wanninger J, Schaffler A, Dada A, Liebisch G, Schmitz G, Aslanidis C, et al. Low molecular weight adiponectin negatively correlates with the waist circumference and monocytic IL-6 release. Biochem Biophys Res Commun 2007; 361: 968–973
   PubMed Web of Science ®Google Scholar
• Tsuchida A, Yamauchi T, Takekawa S, Hada Y, Ito Y, Maki T, Kadowaki T. Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: Comparison of activation of PPARalpha, PPARgamma, and their combination. Diabetes 2005; 54: 3358–3370
   PubMed Web of Science ®Google Scholar
• Ong G K, Hamilton J K, Sermer M, Connelly P W, Maguire G, Zinman B, Hanley A J, Retnakaran R. Maternal serum adiponectin and infant birth weight: The role of adiponectin isoform distribution. Clin Endocrinol (Oxf) 2007; 67: 108–114
   PubMed Web of Science ®Google Scholar
• Retnakaran R, Hanley A J, Connelly P W, Maguire G, Sermer M, Zinman B. Low serum levels of high-molecular weight adiponectin in Indo-Asian women during pregnancy: Evidence of ethnic variation in adiponectin isoform distribution. Diabetes Care 2006; 29: 1377–1379
   PubMed Web of Science ®Google Scholar
• Takemura Y, Osuga Y, Koga K, Tajima T, Hirota Y, Hirata T, Morimoto C, Harada M, Yano T, Taketani Y. Selective increase in high molecular weight adiponectin concentration in serum of women with preeclampsia. J Reprod Immunol 2007; 73: 60–65
   PubMed Web of Science ®Google Scholar
• Retnakaran R, Connelly P W, Maguire G, Sermer M, Zinman B, Hanley A J. Decreased high-molecular-weight adiponectin in gestational diabetes: Implications for the pathophysiology of type 2 diabetes. Diabet Med 2007; 24: 245–252
   PubMed Web of Science ®Google Scholar
• Diet, nutrition and the prevention of chronic diseases. World Health Organ Tech Rep Ser 2003; 916: i–149, backcover
   PubMed Web of Science ®Google Scholar
• Abbasi F, Chu J W, Lamendola C, McLaughlin T, Hayden J, Reaven G M, Reaven P D. Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 2004; 53: 585–590
   PubMed Web of Science ®Google Scholar
• Kern P A, Di Gregorio G B, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue: Relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 2003; 52: 1779–1785
   PubMed Web of Science ®Google Scholar
• Combs T P, Berg A H, Obici S, Scherer P E, Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 2001; 108: 1875–1881
   PubMed Web of Science ®Google Scholar
• Combs T P, Pajvani U B, Berg A H, Lin Y, Jelicks L A, Laplante M, Nawrocki A R, Rajala M W, Parlow A F, Cheeseboro L, et al. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 2004; 145: 367–383
   PubMed Web of Science ®Google Scholar
• Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002; 8: 731–737
   PubMed Web of Science ®Google Scholar
• Nawrocki A R, Rajala M W, Tomas E, Pajvani U B, Saha A K, Trumbauer M E, Pang Z, Chen A S, Ruderman N B, Chen H, et al. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 2006; 281: 2654–2660
   PubMed Web of Science ®Google Scholar
• Tomas E, Tsao T S, Saha A K, Murrey H E, Zhang C C, Itani S I, Lodish H F, Ruderman N B. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci U S A 2002; 99: 16 309–16 313
   Google Scholar
• Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002; 8: 1288–1295
   PubMed Web of Science ®Google Scholar
• Chen H, Montagnani M, Funahashi T, Shimomura I, Quon M J. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003; 278: 45 021–45 026
   Google Scholar
• Funahashi T, Nakamura T, Shimomura I, Maeda K, Kuriyama H, Takahashi M, Arita Y, Kihara S, Matsuzawa Y. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 1999; 38: 202–206
   PubMed Web of Science ®Google Scholar
• Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002; 277: 25 863–25 866
   Google Scholar
• Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, Uchida S, Ito Y, Takakuwa K, Matsui J, et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 2003; 278: 2461–2468
   PubMed Web of Science ®Google Scholar
• Chandran M, Phillips S A, Ciaraldi T, Henry R R. Adiponectin: More than just another fat cell hormone. Diabetes Care 2003; 26: 2442–2450
   PubMed Web of Science ®Google Scholar
• Nawrocki A R, Scherer P E. The delicate balance between fat and muscle: Adipokines in metabolic disease and musculoskeletal inflammation. Curr Opin Pharmacol 2004; 4: 281–289
   PubMed Web of Science ®Google Scholar
• Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, Nagai M, Matsuzawa Y, Funahashi T. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004; 68: 975–981
   PubMed Web of Science ®Google Scholar
• Schulze M B, Rimm E B, Shai I, Rifai N, Hu F B. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care 2004; 27: 1680–1687
   PubMed Web of Science ®Google Scholar
• Shimabukuro M, Higa N, Asahi T, Oshiro Y, Takasu N, Tagawa T, Ueda S, Shimomura I, Funahashi T, Matsuzawa Y. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 2003; 88: 3236–3240
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Hirose H, Saito I, Nishikai K, Saruta T. Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: Two-year follow-up study in Japanese population. J Clin Endocrinol Metab 2004; 89: 87–90
   PubMed Web of Science ®Google Scholar
• Yatagai T, Nishida Y, Nagasaka S, Nakamura T, Tokuyama K, Shindo M, Tanaka H, Ishibashi S. Relationship between exercise training-induced increase in insulin sensitivity and adiponectinemia in healthy men. Endocr J 2003; 50: 233–238
   PubMed Web of Science ®Google Scholar
• Combs T P, Wagner J A, Berger J, Doebber T, Wang W J, Zhang B B, Tanen M, Berg A H, O'Rahilly S, Savage D B, et al. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: A potential mechanism of insulin sensitization. Endocrinology 2002; 143: 998–1007
   PubMed Web of Science ®Google Scholar
• Steffes M W, Gross M D, Schreiner P J, Yu X, Hilner J E, Gingerich R, Jacobs D R, Jr. Serum adiponectin in young adults—interactions with central adiposity, circulating levels of glucose, and insulin resistance: The CARDIA study. Ann Epidemiol 2004; 14: 492–498
   PubMed Web of Science ®Google Scholar
• Mantzoros C S, Li T, Manson J E, Meigs J B, Hu F B. Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab 2005; 90: 4542–4548
   PubMed Web of Science ®Google Scholar
• Shetty G K, Economides P A, Horton E S, Mantzoros C S, Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 2004; 27: 2450–2457
   PubMed Web of Science ®Google Scholar
• Pischon T, Girman C J, Hotamisligil G S, Rifai N, Hu F B, Rimm E B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004; 291: 1730–1737
   PubMed Web of Science ®Google Scholar
• Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23: 85–89
   PubMed Web of Science ®Google Scholar
• Cnop M, Havel P J, Utzschneider K M, Carr D B, Sinha M K, Boyko E J, Retzlaff B M, Knopp R H, Brunzell J D, Kahn S E. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: Evidence for independent roles of age and sex. Diabetologia 2003; 46: 459–469
   PubMed Web of Science ®Google Scholar
• Kantartzis K, Rittig K, Balletshofer B, Machann J, Schick F, Porubska K, Fritsche A, Haring H U, Stefan N. The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity. Clin Chem 2006; 52: 1934–1942
   PubMed Web of Science ®Google Scholar
• Okada T, Saito E, Kuromori Y, Miyashita M, Iwata F, Hara M, Harada K. Relationship between serum adiponectin level and lipid composition in each lipoprotein fraction in adolescent children. Atherosclerosis 2006; 188: 179–183
   Google Scholar
• von E M, Schneider J G, Humpert P M, Kreuzer J, Kuecherer H, Katus H A, Nawroth P P, Dugi K A. Serum adiponectin levels are an independent predictor of the extent of coronary artery disease in men. J Am Coll Cardiol 2006; 47: 2124–2126
   PubMed Web of Science ®Google Scholar
• von E M, Hamann A, Twardella D, Nawroth P P, Brenner H, Rothenbacher D. Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease. Clin Chem 2006; 52: 853–859
   PubMed Web of Science ®Google Scholar
• Nakamura T, Kodama Y, Takano H, Umetani K, Fujioka D, Saito Y, Kawabata K, Obata J E, Kitta Y, Kobayashi T, et al. Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia. Atherosclerosis 2007; 193: 449–451
   Google Scholar
• Westphal S, Borucki K, Taneva E, Makarova R, Luley C. Adipokines and treatment with niacin. Metabolism 2006; 55: 1283–1285
   PubMed Web of Science ®Google Scholar
• Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, Kumada M, Hotta K, Nishida M, Takahashi M, et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002; 105: 2893–2898
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y, Shimomura I, Kihara S, Funahashi T. Importance of adipocytokines in obesity-related diseases. Horm Res 2003; 60(Suppl 3)56–59
   Google Scholar
• Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005; 26: 439–451
   PubMed Web of Science ®Google Scholar
• Koerner A, Kratzsch J, Kiess W. Adipocytokines: Leptin – the classical, resistin – the controversial, adiponectin – the promising, and more to come. Best Pract Res Clin Endocrinol Metab 2005; 19: 525–546
   PubMed Web of Science ®Google Scholar
• Ouchi N, Shibata R, Walsh K. Cardioprotection by adiponectin. Trends Cardiovasc Med 2006; 16: 141–146
   PubMed Web of Science ®Google Scholar
• Scherer P E. Adipose tissue: From lipid storage compartment to endocrine organ. Diabetes 2006; 55: 1537–1545
   PubMed Web of Science ®Google Scholar
• Bora P S, Kaliappan S, Lyzogubov V V, Tytarenko R G, Thotakura S, Viswanathan T, Bora N S. Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin. FEBS Lett 2007; 581: 1977–1982
   PubMed Web of Science ®Google Scholar
• Brakenhielm E, Veitonmaki N, Cao R, Kihara S, Matsuzawa Y, Zhivotovsky B, Funahashi T, Cao Y. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci U S A 2004; 101: 2476–2481
   PubMed Web of Science ®Google Scholar
• Vona-Davis L, Howard-McNatt M, Rose D P. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev 2007; 8: 395–408
   PubMed Web of Science ®Google Scholar
• Butte N F, Wong W W, Treuth M S, Ellis K J, O'Brian S E. Energy requirements during pregnancy based on total energy expenditure and energy deposition. Am J Clin Nutr 2004; 79: 1078–1087
   PubMed Web of Science ®Google Scholar
• Catalano P M. Management of obesity in pregnancy. Obstet Gynecol 2007; 109: 419–433
   PubMed Web of Science ®Google Scholar
• Ehrenberg H M, Huston-Presley L, Catalano P M. The influence of obesity and gestational diabetes mellitus on accretion and the distribution of adipose tissue in pregnancy. Am J Obstet Gynecol 2003; 189: 944–948
   PubMedGoogle Scholar
• Hytten F E, Chamberlain G. Clinical physiology in obstetrics. Blackwell Scientifc Publications, OxfordUnited Kingdom 1991
   Google Scholar
• Kinoshita T, Itoh M. Longitudinal variance of fat mass deposition during pregnancy evaluated by ultrasonography: The ratio of visceral fat to subcutaneous fat in the abdomen. Gynecol Obstet Invest 2006; 61: 115–118
   PubMed Web of Science ®Google Scholar
• Pipe N G, Smith T, Halliday D, Edmonds C J, Williams C, Coltart T M. Changes in fat, fat-free mass and body water in human normal pregnancy. Br J Obstet Gynaecol 1979; 86: 929–940
   PubMedGoogle Scholar
• Aberg A, Rydhstroem H, Frid A. Impaired glucose tolerance associated with adverse pregnancy outcome: A population-based study in southern Sweden. Am J Obstet Gynecol 2001; 184: 77–83
   PubMed Web of Science ®Google Scholar
• Al-Shawaf T, Moghraby S, Akiel A. Does impaired glucose tolerance imply a risk in pregnancy. Br J Obstet Gynaecol 1988; 95: 1036–1041
   Google Scholar
• Dixon J B, Dixon M E, O'Brien P E. Birth outcomes in obese women after laparoscopic adjustable gastric banding. Obstet Gynecol 2005; 106: 965–972
   PubMed Web of Science ®Google Scholar
• Weiss J L, Malone F D, Emig D, Ball R H, Nyberg D A, Comstock C H, Saade G, Eddleman K, Carter S M, Craigo S D, et al. Obesity, obstetric complications and cesarean delivery rate—a population-based screening study. Am J Obstet Gynecol 2004; 190: 1091–1097
   PubMed Web of Science ®Google Scholar
• Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA 1991; 266: 237–241
   PubMed Web of Science ®Google Scholar
• Joffe G M, Esterlitz J R, Levine R J, Clemens J D, Ewell M G, Sibai B M, Catalano P M. The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) study group. Am J Obstet Gynecol 1998; 179: 1032–1037
   PubMed Web of Science ®Google Scholar
• Sibai B M, Gordon T, Thom E, Caritis S N, Klebanoff M, McNellis D, Paul R H. Risk factors for preeclampsia in healthy nulliparous women: A prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal–Fetal Medicine Units. Am J Obstet Gynecol 1995; 172: 642–648
   PubMed Web of Science ®Google Scholar
• Solomon C G, Seely E W. Hypertension in pregnancy: A manifestation of the insulin resistance syndrome. Hypertension 2001; 37: 232–239
   PubMed Web of Science ®Google Scholar
• Wolf M, Sandler L, Munoz K, Hsu K, Ecker J L, Thadhani R. First trimester insulin resistance and subsequent preeclampsia: A prospective study. J Clin Endocrinol Metab 2002; 87: 1563–1568
   PubMed Web of Science ®Google Scholar
• Crowther C A, Hiller J E, Moss J R, McPhee A J, Jeffries W S, Robinson J S. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352: 2477–2486
   PubMed Web of Science ®Google Scholar
• Yogev Y, Xenakis E M, Langer O. The association between preeclampsia and the severity of gestational diabetes: The impact of glycemic control. Am J Obstet Gynecol 2004; 191: 1655–1660
   PubMed Web of Science ®Google Scholar
• D'Anna R, Baviera G, Corrado F, Giordano D, Di Benedetto A, Jasonni V M. Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders. Obstet Gynecol 2005; 106: 340–344
   PubMed Web of Science ®Google Scholar
• Suwaki N, Masuyama H, Nakatsukasa H, Masumoto A, Sumida Y, Takamoto N, Hiramatsu Y. Hypoadiponectinemia and circulating angiogenic factors in overweight patients complicated with pre-eclampsia. Am J Obstet Gynecol 2006
   Google Scholar
• Crouch E, Persson A, Chang D, Heuser J. Molecular structure of pulmonary surfactant protein D (SP-D). J Biol Chem 1994; 269: 17 311–17 319
   Google Scholar
• McCormack F X, Pattanajitvilai S, Stewart J, Possmayer F, Inchley K, Voelker D R. The Cys6 intermolecular disulfide bond and the collagen-like region of rat SP-A play critical roles in interactions with alveolar type II cells and surfactant lipids. J Biol Chem 1997; 272: 27 971–27 979
   Google Scholar
• Wong G W, Wang J, Hug C, Tsao T S, Lodish H F. A family of Acrp30/adiponectin structural and functional paralogs. Proc Natl Acad Sci U S A 2004; 101: 10 302–10 307
   Google Scholar
• Wang Y, Xu A, Knight C, Xu L Y, Cooper G J. Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity. J Biol Chem 2002; 277: 19 521–19 529
   Google Scholar
• Wang Y, Lam K S, Chan L, Chan K W, Lam J B, Lam M C, Hoo R C, Mak W W, Cooper G J, Xu A. Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex. J Biol Chem 2006; 281: 16 391–16 400
   Google Scholar
• Phillips S A, Ciaraldi T P, Kong A P, Bandukwala R, Aroda V, Carter L, Baxi S, Mudaliar S R, Henry R R. Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy. Diabetes 2003; 52: 667–674
   PubMed Web of Science ®Google Scholar
• Abke S, Neumeier M, Weigert J, Wehrwein G, Eggenhofer E, Schaffler A, Maier K, Aslanidis C, Scholmerich J, Buechler C. Adiponectin-induced secretion of interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1, CCL2) and interleukin-8 (IL-8, CXCL8) is impaired in monocytes from patients with type I diabetes. Cardiovasc Diabetol 2006; 5: 17
   PubMed Web of Science ®Google Scholar
• Rovin B H, Song H. Chemokine induction by the adipocyte-derived cytokine adiponectin. Clin Immunol 2006; 120: 99–105
   PubMed Web of Science ®Google Scholar
• Haugen F, Drevon C A. Activation of nuclear factor-kappaB by high molecular weight and globular adiponectin. Endocrinology 2007; 148: 5478–5486
   PubMed Web of Science ®Google Scholar
• Neumeier M, Weigert J, Schaffler A, Wehrwein G, Muller-Ladner U, Scholmerich J, Wrede C, Buechler C. Different effects of adiponectin isoforms in human monocytic cells. J Leukoc Biol 2006; 79: 803–808
   PubMed Web of Science ®Google Scholar
• Tasanen K, Eble J A, Aumailley M, Schumann H, Baetge J, Tu H, Bruckner P, Bruckner-Tuderman L. Collagen XVII is destabilized by a glycine substitution mutation in the cell adhesion domain Col15. J Biol Chem 2000; 275: 3093–3099
   Google Scholar
• Lara-Castro C, Luo N, Wallace P, Klein R L, Garvey W T. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006; 55: 249–259
   PubMed Web of Science ®Google Scholar
• Wang A Y, Hickman I J, Richards A A, Whitehead J P, Prins J B, Macdonald G A. High molecular weight adiponectin correlates with insulin sensitivity in patients with hepatitis C genotype 3, but not genotype 1 infection. Am J Gastroenterol 2005; 100: 2717–2723
   Google Scholar
• Iwahashi H, Funahashi T, Kurokawa N, Sayama K, Fukuda E, Okita K, Imagawa A, Yamagata K, Shimomura I, Miyagawa J I, et al. Plasma adiponectin levels in women with anorexia nervosa. Horm Metab Res 2003; 35: 537–540
   PubMed Web of Science ®Google Scholar
• Ebinuma H, Miyazaki O, Yago H, Hara K, Yamauchi T, Kadowaki T. A novel ELISA system for selective measurement of human adiponectin multimers by using proteases. Clin Chim Acta 2006; 372: 47–53
   PubMed Web of Science ®Google Scholar
• Ebinuma H, Miida T, Yamauchi T, Hada Y, Hara K, Kubota N, Kadowaki T. Improved ELISA for selective measurement of adiponectin multimers and identification of adiponectin in human cerebrospinal fluid. Clin Chem 2007; 53: 1541–1544
   PubMed Web of Science ®Google Scholar
• Nakano Y, Tajima S, Yoshimi A, Akiyama H, Tsushima M, Tanioka T, Negoro T, Tomita M, Tobe T. A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin. J Lipid Res 2006; 47: 1572–1582
   PubMed Web of Science ®Google Scholar
• Hammarstedt A, Sopasakis V R, Gogg S, Jansson P A, Smith U. Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects. Diabetologia 2005; 48: 96–104
   Google Scholar
• Fuglsang J, Skjaerbaek C, Frystyk J, Flyvbjerg A, Ovesen P. A longitudinal study of serum adiponectin during normal pregnancy. BJOG 2006; 113: 110–113
   PubMed Web of Science ®Google Scholar
• Catalano P M, Nizielski S E, Shao J, Preston L, Qiao L, Friedman J E. Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: Relationship to FFA during pregnancy. Am J Physiol Endocrinol Metab 2002; 282: E522–533
   PubMed Web of Science ®Google Scholar
• Desoye G, Schweditsch M O, Pfeiffer K P, Zechner R, Kostner G M. Correlation of hormones with lipid and lipoprotein levels during normal pregnancy and postpartum. J Clin Endocrinol Metab 1987; 64: 704–712
   PubMed Web of Science ®Google Scholar
• Paradisi G, Biaggi A, Ferrazzani S, De C S, Caruso A. Abnormal carbohydrate metabolism during pregnancy: Association with endothelial dysfunction. Diabetes Care 2002; 25: 560–564
   PubMed Web of Science ®Google Scholar
• Sivan E, Homko C J, Chen X, Reece E A, Boden G. Effect of insulin on fat metabolism during and after normal pregnancy. Diabetes 1999; 48: 834–838
   PubMed Web of Science ®Google Scholar
• Faust I M, Johnson P R, Stern J S, Hirsch J. Diet-induced adipocyte number increase in adult rats: A new model of obesity. Am J Physiol 1978; 235: E279–286
   PubMed Web of Science ®Google Scholar
• Garaulet M, Hernandez-Morante J J, Lujan J, Tebar F J, Zamora S. Relationship between fat cell size and number and fatty acid composition in adipose tissue from different fat depots in overweight/obese humans. Int J Obes (Lond) 2006; 30: 899–905
   Web of Science ®Google Scholar
• Hausman D B, DiGirolamo M, Bartness T J, Hausman G J, Martin R J. The biology of white adipocyte proliferation. Obes Rev 2001; 2: 239–254
   PubMedGoogle Scholar
• Hirsch J, Batchelor B. Adipose tissue cellularity in human obesity. Clin Endocrinol Metab 1976; 5: 299–311
   PubMedGoogle Scholar
• Johnson P R, Stern J S, Greenwood M R, Hirsch J. Adipose tissue hyperplasia and hyperinsulinemia on Zucker obese female rats: A developmental study. Metabolism 1978; 27: 1941–1954
   PubMed Web of Science ®Google Scholar
• Prins J B, O'Rahilly S. Regulation of adipose cell number in man. Clin Sci (Lond) 1997; 92: 3–11
   PubMed Web of Science ®Google Scholar
• Tontonoz P, Hu E, Spiegelman B M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994; 79: 1147–1156
   PubMed Web of Science ®Google Scholar
• Yu J G, Javorschi S, Hevener A L, Kruszynska Y T, Norman R A, Sinha M, Olefsky J M. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 2002; 51: 2968–2974
   PubMed Web of Science ®Google Scholar
• He W, Barak Y, Hevener A, Olson P, Liao D, Le J, Nelson M, Ong E, Olefsky J M, Evans R M. Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci U S A 2003; 100: 15 712–15 717
   Google Scholar
• Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsuzawa Y, Makishima M, Shimomura I. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003; 52: 1655–1663
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K, Ide T, Kubota N, Terauchi Y, Tobe K, et al. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J Biol Chem 2001; 276: 41 245–41 254
   Google Scholar
• Yang W S, Jeng C Y, Wu T J, Tanaka S, Funahashi T, Matsuzawa Y, Wang J P, Chen C L, Tai T Y, Chuang L M. Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care 2002; 25: 376–380
   PubMed Web of Science ®Google Scholar
• de Souza C J, Eckhardt M, Gagen K, Dong M, Chen W, Laurent D, Burkey B F. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes 2001; 50: 1863–1871
   PubMed Web of Science ®Google Scholar
• De V P, Lefebvre A M, Miller S G, Guerre-Millo M, Wong K, Saladin R, Hamann L G, Staels B, Briggs M R, Auwerx J. Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma. J Clin Invest 1996; 98: 1004–1009
   Google Scholar
• Hulver M W, Zheng D, Tanner C J, Houmard J A, Kraus W E, Slentz C A, Sinha M K, Pories W J, MacDonald K G, Dohm G L. Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab 2002; 283: E861–865
   PubMed Web of Science ®Google Scholar
• Kopp H P, Krzyzanowska K, Mohlig M, Spranger J, Pfeiffer A F, Schernthaner G. Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes (Lond) 2005; 29: 766–771
   PubMed Web of Science ®Google Scholar
• Faraj M, Havel P J, Phelis S, Blank D, Sniderman A D, Cianflone K. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2003; 88: 1594–1602
   PubMed Web of Science ®Google Scholar
• Pender C, Goldfine I D, Tanner C J, Pories W J, MacDonald K G, Havel P J, Houmard J A, Youngren J F. Muscle insulin receptor concentrations in obese patients post bariatric surgery: Relationship to hyperinsulinemia. Int J Obes Relat Metab Disord 2004; 28: 363–369
   Google Scholar
• Polak J, Kovacova Z, Jacek M, Klimcakova E, Kovacikova M, Vitkova M, Kuda O, Sebela M, Samcova E, Stich V. An increase in plasma adiponectin multimeric complexes follows hypocaloric diet-induced weight loss in obese and overweight pre-menopausal women. Clin Sci (Lond) 2007; 112: 557–565
   Google Scholar
• Delporte M L, Brichard S M, Hermans M P, Beguin C, Lambert M. Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol (Oxf) 2003; 58: 22–29
   PubMed Web of Science ®Google Scholar
• Pannacciulli N, Vettor R, Milan G, Granzotto M, Catucci A, Federspil G, De G P, Giorgino R, De P G. Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism. J Clin Endocrinol Metab 2003; 88: 1748–1752
   PubMed Web of Science ®Google Scholar